ClinicalTrials.gg
CompletedNCT06104995Updated Oct 9, 2026

Back Beliefs Among the General Population

An interventional study of Interventional video and Control video in Low Back Pain, sponsored by Bern University of Applied Sciences. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Bern University of Applied Sciences · Not applicable, Interventional, and Other

Updated Oct 9, 2026Enrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
237
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-15

Among 46 studies in Low Back Pain with a site in Switzerland — 8 open to participants now, 8 under way, none of them phase 3. Low Back Pain · Switzerland.

Enrollment
3rd of 31
237 · median 102
Started
2023
with 7 others
No phase
26 of 46
6 open now
Registered
39th of 46
by date
Lead sponsor
3 of 46
Bern University of Applied Sciences

Among the 46 studies in Low Back Pain with a site in Switzerland, this one is the 3rd largest by enrollment of the 31 interventional ones that give a count, is one of 8 that started in 2023, is one of 26 with no phase, and was the 39th registered.

Low Back Pain

2,923 studies on the registry are indexed under Low Back Pain; 579 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

8 of the 46 studies in Low Back Pain with a site in Switzerland are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 92 (28%) set no upper age limit and 210 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Low Back Pain with a site in Switzerland, or all of them as a file.
02

Study summary

In the current study we aim to evaluate the effects of a short educational video on improving the belief that "the back is fragile and needs to be protected" among the German speaking Swiss general population. We hypothesize that a short video education program can positively change the assessed back belief among the German speaking general population of Switzerland.

To evaluate the outcomes, we will use the 10-item version of the Back Pain Attitude Questionnaire (Back-PAQ). The primary outcome is the second question of the Back-PAQ-10 ("You could injure your back if you are not careful"). The secondary outcome of this study is the total score of the Back-PAQ-10.

The design of the present study is a two-group randomized controlled trial, with one intervention and one control group in a 1:1 allocation.

Read the detailed description

This study will be conducted in collaboration with HESAV (Haute Ecole de Sante Vaud). The research group at the HESAV has developed an educational website in 2020, called "www.infomaldedos.ch". The website aims to educate people on low back pain, and common unhelpful beliefs about the back - primarily targeting the belief about the fragility of the back and the need for its protection - are addressed. In the current study we are going to translate the above-mentioned website to the German language. Furthermore, we are going to assess the quality and applicability of a short video intervention among the general population, using one of the videos from the website.

Participants will be recruited through social media and emails. A link will be created to the questionnaire and the educational video with LimeSurvey. A 'randomizer' built-in function will be used to blindly split people into intervention or control group. The link will be spread on social media platforms and through email. To induce a snowball sampling method, all participants will be asked to send the link further.

The length of the video intervention is 3 minutes. In the video, health care professionals, such as a psychologist, a medical doctor, a professor, and physiotherapist interviewed by a scientist explains the burden of LBP, how unhelpful beliefs affect treatment outcome, difficulties in the management of LBP and the optimal way of treating LBP. The scientist then inquires a representative patient about their own experiences of the management of LBP. At the end of the video the scientist encourages people to exercise despite LBP by performing various movements.

The control group will receive a neutral video about the back, selected from YouTube.

03

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • nonspecific low back pain
  • back beliefs
  • education
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age >18 years

Exclusion criteria

Exclusion Criteria:

  • Professionals and students with prior knowledge on the topic of interest such as physiotherapists, osteopaths, and chiropractors.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
237 participants (actual)

Study arms

  • Experimental
    Interventional Educational video on back beliefs

    Participants receive an educational video on back beliefs and its contributing factors.

    Other: Interventional video

  • Experimental
    Control Video Education

    Participants receive a neutral video about the back (e.g. anatomy of the back).

    Other: Control video

Interventions

  • OtherInterventional video

    The educational video comprises of health care professionals explaining the durability of the back against the popular belief that the back is fragile and the multifactorial nature of back pain.

  • OtherControl video

    The control video is a neutral video with no content addressing back beliefs (fragility and need for protection).

06

What researchers measure

Primary outcomes

  1. Sentiments about back vulnerability

    The primary outcome is the second question of the Back-PAQ-10 ("You could injure your back if you are not careful")

    Time frame: One minute

Secondary outcomes

  1. Total Back-PAQ-10 score

    The secondary outcome of this study is the total score of the German version of the Back-PAQ-10.

    Time frame: Three minutes

07

Study locations

1 site
  • Bern University of Applied Sciences
    Bern, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in Jul 2024, 8 months.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 8 months is below that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2023
First posted
Oct 27, 2023
StartActual
Nov 15, 2023
Primary completionActual
Jul 31, 2024
CompletionActual
Jul 31, 2024
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
232→237
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Enrollment 232→237
    + 1 other change: index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06104995
Lead sponsor
Bern University of Applied Sciences
Collaborators
Haute Ecole de Santé Vaud
Responsible party
Stefan Schmid (Deputy Head of Research at the Division of Physiotherapy and Head of Spinal Movement Biomechanics Group, Bern University of Applied Sciences) — Principal investigator
First posted
Oct 27, 2023
Start date
Nov 15, 2023
Primary completion
Jul 31, 2024
Completion
Jul 31, 2024
Last update
Oct 9, 2026

Study contacts

Stefan Schmid, PhD
principal investigator · Bern UAS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion